Cited by 381Posttraumatic Stress Disorder ResearchStress Responses and CortisolNeurotransmitter Receptor Influence on Behavior

The effects of stress exposure on prefrontal cortex: Translating basic research into successful treatments for post-traumatic stress disorder

Open access
Arnsten, Amy F.T., Raskind, Murray A., Taylor, Fletcher B., Connor, Daniel F.·2015·Neurobiology of Stress

Abstract

Research on the neurobiology of the stress response in animals has led to successful new treatments for Post-Traumatic Stress Disorder (PTSD) in humans. Basic research has found that high levels of catecholamine release during stress rapidly impair the top-down cognitive functions of the prefrontal cortex (PFC), while strengthening the emotional and habitual responses of the amygdala and basal ganglia. Chronic stress exposure leads to dendritic atrophy in PFC, dendritic extension in the amygdala, and strengthening of the noradrenergic (NE) system. High levels of NE release during stress engage low affinity alpha-1 adrenoceptors, (and likely beta-1 adrenoceptors), which rapidly reduce the firing of PFC neurons, but strengthen amygdala function. In contrast, moderate levels of NE release during nonstress conditions engage higher affinity alpha-2A receptors, which strengthen PFC, weaken amygdala, and regulate NE cell firing. Thus, either alpha-1 receptor blockade or alpha-2A receptor stimulation can protect PFC function during stress. Patients with PTSD have signs of PFC dysfunction. Clinical studies have found that blocking alpha-1 receptors with prazosin, or stimulating alpha-2A receptors with guanfacine or clonidine can be useful in reducing the symptoms of PTSD. Placebo-controlled trials have shown that prazosin is helpful in veterans, active duty soldiers and civilians with PTSD, including improvement of PFC symptoms such as impaired concentration and impulse control. Open label studies suggest that guanfacine may be especially helpful in treating children and adolescents who have experienced trauma. Thus, understanding the neurobiology of the stress response has begun to help patients with stress disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ynstr.2014.10.002

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Changes in neural circuitry caused by chronic stress are believed to underlie the deficits in learning/memory, mood, motivation, and reward seeking that are characteristic of depression and related disorders.

    “these changes in neural circuitry are believed to underlie the deficits in learning/memory, mood, motivation, and reward seeking that are characteristic of depression and related disorders (10, 67–74)”

    From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [72]

    In “Chronic stress accentuates these actions” (page not provided), the paper links stress-related circuit changes to impaired working memory and describes persistent changes in circuits regulating behavior and emotion. It does not link those changes to deficits in motivation or reward seeking, or establish the full set of deficits as characteristic of depression and related disorders. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Guanfacine has been especially useful in treating traumatized or abused children, who often have PFC dysfunction reflected in symptoms of impaired self-control.

    “Guanfacine has been especially useful in treating traumatized or abused children, who often have PFC dysfunction reflected in symptoms of impaired self-control.”

    From Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species (2020) · cites this paper as Arnsten et al., 2015

    The Abstract says open-label studies suggest guanfacine may be especially helpful for children and adolescents who have experienced trauma. The sections on treatment and symptoms in children link traumatic stress to PFC dysfunction and impaired impulse control. But the claim presents guanfacine's usefulness as established, whereas the paper says the pediatric evidence is preliminary and notes that there are no controlled trials. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Prazosin reduces flashbacks.

    “Prazosin reduces flashbacks, improves concentration and thinking, and reduces substance abuse, signs of improved PFC function.”

    From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [111]

    In the section on prazosin treatment for adults with PTSD (page unavailable), the review reports reduced nightmares and improvement in the broader reexperiencing symptom cluster. It does not report a reduction in flashbacks specifically, so the claim is more specific than the evidence in our copy. (LLM, conf=0.80)

    Experimental — accuracy not yet measured
  • Prazosin reduces substance abuse.

    “Prazosin reduces flashbacks, improves concentration and thinking, and reduces substance abuse, signs of improved PFC function.”

    From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [111]

    In “The use of the alpha-1 receptor antagonist, prazosin, for adults with PTSD” (page not provided), the paper says prazosin may help reduce substance abuse. It cites preliminary trials showing reduced alcohol craving and use in people without PTSD, so the unqualified claim that prazosin reduces substance abuse overstates the evidence reported. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • The α1-AR antagonist prazosin is in widespread use to treat PTSD in veterans, active duty soldiers and civilians.

    “The α1-AR antagonist prazosin is now in widespread use to treat PTSD in veterans, active duty soldiers and civilians (reviewed in ref. 111).”

    From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [111]

    The section on prazosin for adults with PTSD identifies it as an alpha-1 blocker and reviews treatment studies in veterans, active-duty soldiers, and civilians (page not provided). It does not establish that prazosin was in widespread clinical use in those groups; the cited passages describe trials rather than prescribing prevalence. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 116

  1. Amat J. Paul E. Zarza C. Watkins L.R. Maier S.F. Previous experience with behavioral control over stress blocks the behavioral and dorsal raphe nucleus activating effects of later uncontrollable stress: role of the ventral medial prefrontal cortex J. Neurosci. 26 2006 13264 13272 17182776 PMC6675012
  2. Ansell E.B. Rando K. Tuit K. Guarnaccia J. Sinha R. Cumulative adversity and smaller gray matter volume in medial prefrontal, anterior cingulate, and insula regions Biol. Psychiatry 72 2012 57 64 22218286 PMC3391585
  3. Arnsten A.F.T. Goldman-Rakic P.S. Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism Arch. Gen. Psychiatry 55 1998 362 369 9554432
  4. Arnsten A.F.T. Jentsch J.D. The alpha-1 adrenergic agonist, cirazoline, impairs spatial working memory performance in aged monkeys Pharmacol. Biochem. Behav. 58 1997 55 59 9264070
  5. Arnsten A.F. Jin L.E. Molecular influences on working memory circuits in dorsolateral prefrontal cortex Prog. Mol. Biol. Transl. Sci. 122 2014 211 231 24484703
  6. Arnsten A.F.T. Cai J.X. Murphy B.L. Goldman-Rakic P.S. Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys Psychopharmacology 116 1994 143 151 7862943
  7. Aron A.R. From reactive to proactive and selective control: developing a richer model for stopping inappropriate responses Biol. Psychiatry 69 2011 e55 68 20932513 PMC3039712
  8. Barbas H. Pandya D.N. Architecture and intrinsic connections of the prefrontal cortex in the rhesus monkey J. Comp. Neurol. 286 1989 353 375 2768563
  9. Barbas H. Medalla M. Alade O. Suski J. Zikopoulos B. Lera P. Relationship of prefrontal connections to inhibitory systems in superior temporal areas in the rhesus monkey Cereb. Cortex 15 2005 1356 1370 15635060
  10. Barrash J. Tranel D. Anderson S.W. Acquired personality disturbances associated with bilateral damage to the ventromedial prefrontal region Dev. Neuropsychol. 18 2000 355 381 11385830
  11. Bethea C.L. Kim A. Cameron J.L. Function and innervation of the locus ceruleus in a macaque model of Functional Hypothalamic Amenorrhea Neurobiol. Dis. 50 2013 96 106 23069677 PMC3533527
  12. Birnbaum S.G. Gobeske K.T. Auerbach J. Taylor J.R. Arnsten A.F.T. A role for norepinephrine in stress-induced cognitive deficits: Alpha-1-adrenoceptor mediation in prefrontal cortex Biol. Psychiatry 46 1999 1266 1274 10560032
  13. Bonini J.S. Cammarota M. Kerr D.S. Bevilaqua L.R. Izquierdo I. Inhibition of PKC in basolateral amygdala and posterior parietal cortex impairs consolidation of inhibitory avoidance memory Pharmacol. Biochem. Behav. 80 2005 63 67 15652381
  14. Boscarino J.A. Erlich P.M. Hoffman S.N. Zhang X. Higher FKBP5, COMT, CHRNA5, and CRHR1 allele burdens are associated with PTSD and interact with trauma exposure: implications for neuropsychiatric research and treatment Neuropsychiatr. Dis. Treat. 8 2012 131 139 22536069 PMC3333786
  15. Bremner J.D. Innis R.B. Ng C.K. Staib L.H. Salomon R.M. Bronen R.A. Duncan J. Southwick S.M. Krystal J.H. Rich D. Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder Arch. Gen. Psychiatry 54 1997 246 254 9075465
  16. Bremner J.D. Vythilingam M. Vermetten E. Southwick S.M. McGlashan T. Staib L.H. Soufer R. Charney D.S. Neural correlates of declarative memory for emotionally valenced words in women with posttraumatic stress disorder related to early childhood sexual abuse Biol. Psychiatry 53 2003 879 889 12742675
  17. Breslau N. Chilcoat H.D. Kessler R.C. Peterson E.L. Lucia V.C. Vulnerability to assaultive violence: further specification of the sex difference in post-traumatic stress disorder Psychol. Med. 29 1999 813 821 10473308
  18. Brkanac Z. Pastor J.F. Storck M. Prazosin in PTSD [Case reports – Letter] J. Am. Acad. Child Adolesc. Psychiatry 42 2003 384 385 12649625
  19. Bromberg-Martin E.S. Matsumoto M. Hikosaka O. Dopamine in motivational control: rewarding, aversive, and alerting Neuron 68 2010 815 834 21144997 PMC3032992
  20. Calohan J. Peterson K. Peskind E.R. Raskind M.A. Prazosin treatment of trauma nightmares and sleep disturbance in soldiers deployed in Iraq J. Trauma Stress 23 2010 645 648 20931662
  21. Chaijale N.N. Curtis A.L. Wood S.K. Zhang X.Y. Bhatnagar S. Reyes B.A. Van Bockstaele E.J. Valentino R.J. Social stress engages opioid regulation of locus coeruleus norepinephrine neurons and induces a state of cellular and physical opiate dependence Neuropsychopharmacology 38 2013 1833 1843 23660707 PMC3746692
  22. Chao L.L. Knight R.T. Human prefrontal lesions increase distractibility to irrelevant sensory inputs Neuroreport 6 1995 1605 1610 8527724
  23. Chen C. Chen C. Moyzis R. Dong Q. He Q. Zhu B. Li J. Li H. Li J. Lessard J. Sex modulates the associations between the COMT gene and personality traits Neuropsychopharmacology 36 2011 1593 1598 21471954 PMC3138659
  24. Connor D.F. Ford J.D. Albert D.B. Doerfler L.A. Conduct disorder subtype and comorbidity Ann. Clin. Psychiatry 19 2007 161 168 17729017
  25. Connor D.F. Grasso D.J. Slivinsky M.D. Pearson G.S. Banga A. An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents J. Child Adolesc. Psychopharmacol. 23 2013 244 251 23683139 PMC3657282
  26. Davis M. The role of the amygdala in fear and anxiety Annu. Rev. Neurosci. 15 1992 353 375 1575447
  27. Davis L.L. Ward C. Rasmusson A. Newell J.M. Frazier E. Southwick S.M. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans Psychopharmacol. Bull. 41 2008 8 18 18362867
  28. Deans K.J. Thackeray J. Askegard-Giesmann J.R. Earley E. Groner J.I. Minneci P.C. Mortality increases with recurrent episodes of nonaccidental trauma in children J. Trauma Acute Care Surg. 75 2013 161 165 23940863
  29. DeBock F. Kurz J. Azad S.C. Parsons C.G. Hapfelmeier G. Zieglgansberger W. Rammes G. Alpha2-adrenoreceptor activation inhibits LTP and LTD in the basolateral amygdala: involvement of Gi/o-protein-mediated modulation of Ca2+-channels and inwardly rectifying K+-channels in LTD Eur. J. Neurosci. 17 2003 1411 1424 12713644
  30. Desmeules J. Piguet V. Besson M. Chabert J. Rapiti E. Rebsamen M. Rossier M.F. Curtin F. Dayer P. Cedraschi C. Psychological distress in fibromyalgia patients: a role for catechol-O-methyl-transferase Val158met polymorphism Health Psychol. 31 2012 242 249 21895373
  31. Deutch A.Y. Roth R.H. The determinants of stress-induced activation of the prefrontal cortical dopamine system Prog. Brain Res. 85 1990 367 403 2094906
  32. Elliott A.E. Packard M.G. Intra-amygdala anxiogenic drug infusion prior to retrieval biases rats towards the use of habit memory Neurobiol. Learn Mem. 90 2008 616 623 18662795
  33. Elsayed M. Banasr M. Duric V. Fournier N.M. Licznerski P. Duman R.S. Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression Biol. Psychiatry 72 2012 258 265 22513055 PMC3401338
  34. Elston G.N. Benavides-Piccione R. Elston A. Zietsch B. Defelipe J. Manger P. Casagrande V. Kaas J.H. Specializations of the granular prefrontal cortex of primates: implications for cognitive processing Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 288 2006 26 35 16342214
  35. Engberg G. Eriksson E. Effects of alpha-2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in EEDQ-treated rats Naunyn-Schmiedebergs Arch. Pharmacol. 343 1991 472 477 1652697
  36. Fan Y. Chen P. Li Y. Zhu M.Y. Effects of chronic social defeat on expression of dopamine β-hydroxylase in rat brains Synapse 67 2013 300 312 23389997 PMC9338777
  37. Ferry B. Roozendaal B. McGaugh J.L. Basolateral amygdala noradrenergic influences on memory storage are mediated by an interaction between beta- and alpha-1-adrenoceptors J. Neurosci. 19 1999 5119 5123 10366644 PMC6782651
  38. Ford J.D. Wasser T. Connor D.F. Identifying and determining the symptom severity associated with polyvictimization among psychiatrically impaired children in the outpatient setting Child Maltreat. 16 2011 216 226 21493616
  39. Fox H. Sinha R. The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals Adv. Pharmacol. 69 2014 217 265 24484979 PMC4017947
  40. Fox H.C. Anderson G.M. Tuit K. Hansen J. Kimmerling A. Siedlarz K.M. Morgan P.T. Sinha R. Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings Alcohol Clin. Exp. Res. 36 2012 351 360 21919922 PMC3243763
  41. Fox H.C. Seo D. Tuit K. Hansen J. Kimmerling A. Morgan P.T. Sinha R. Guanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: preliminary findings J. Psychopharmacol. 26 2012 958 972 22234929 PMC3694403
  42. Fraleigh L.A. Hendratta V.D. Ford J.D. Connor D.F. Prazosin for the treatment of posttraumatic stress disorder-related nightmares in an adolescent male J. Child Adolesc. Psychopharmacol. 19 2009 475 476 19702502
  43. Gamo N.J. Wang M. Lur G. Higley M.J. Susheel Vijayraghavan S. Yang Y. Ramos B.R. Peng K. Kata A. Boven L. Stress impairs prefrontal cortical function via D1 dopamine receptor interactions with HCN channels Biol. Psychiat. 2014 (in submission) PMC4524795 25731884
  44. Geracioti T.D. Jr. Baker D.G. Ekhator N.N. West S.A. Hill K.K. Bruce A.B. Schmidt D. Rounds-Kugler B. Yehuda R. Keck P.E. Jr. CSF norepinephrine concentrations in posttraumatic stress disorder Am. J. Psychiatry 158 2001 1227 1230 11481155
  45. Germain A. Richardson R. Moul D.E. Mammen O. Haas G. Forman S.D. Rode N. Begley A. Nofzinger E.A. Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US Military Veterans J. Psychosom. Res. 72 2012 89 96 22281448 PMC3267960
  46. Ghashghaei H.T. Barbas H. Pathways for emotion: interactions of prefrontal and anterior temporal pathways in the amygdala of the rhesus monkey Neuroscience 115 2002 1261 1279 12453496
  47. Golden C.J. Identification of brain disorders by the Stroop Color and Word Test Clin. Psychol. 32 1976 654 658 956433
  48. Goldman-Rakic P.S. Cellular basis of working memory Neuron 14 1995 477 485 7695894
  49. Goldman-Rakic P.S. The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive Phil. Trans. R. Soc. Lond. 351 1996 1445 1453 8941956
  50. Harmon R.J. Riggs P.D. Clonidine for posttraumatic stress disorder in preschool children J. Am. Acad. Child Adolesc. Psychiatry 35 1996 1247 1249 8824068
  51. Herringa R. Phillips M. Almeida J. Insana S. Germain A. Post-traumatic stress symptoms correlate with smaller subgenual cingulate, caudate, and insula volumes in unmedicated combat veterans Psychiatry Res. 203 2012 139 145 23021615 PMC3466380
  52. Hobson J.A. Sleep and dreaming: induction and mediation of REM sleep by cholinergic mechanisms Curr. Opin. Neurobiol. 2 1992 759 763 1477541
  53. Horrigan J.P. Guanfacine for PTSD nightmares J. Am. Acad. Child Adolesc. Psychiatry 35 1996 975 976 8755792
  54. Jedema H.P. Grace A.A. Chronic exposure to cold stress alters electrophysiological properties of locus coeruleus neurons recorded in vitro Neuropsychopharmacology 28 2003 63 72 12496941
  55. Kim J.J. Yoon K.S. Stress: metaplastic effects in the hippocampus Trends Neurosci. 21 1998 505 509 9881846
  56. Kodama T. Hikosaka K. Honda Y. Kojima T. Watanabe M. Higher dopamine release induced by less rather than more preferred reward during a working memory task in the primate prefrontal cortex Behav. Brain Res. 266 2014 104 107 24556206
  57. Koenen K.C. Driver K.L. Oscar-Berman M. Wolfe J. Folsom S. Huang M.T. Schlesinger L. Measures of prefrontal system dysfunction in posttraumatic stress disorder Brain Cogn. 45 2001 64 78 11161363
  58. Kolassa I.T. Kolassa S. Ertl V. Papassotiropoulos A. De Quervain D.J. The risk of posttraumatic stress disorder after trauma depends on traumatic load and the catechol-o-methyltransferase Val(158)Met polymorphism Biol. Psychiatry 67 2010 304 308 19944409
  59. Koola M.M. Varghese S.P. Fawcett J.A. High-dose prazosin for the treatment of post-traumatic stress disorder Ther. Adv. Psychopharmacol. 4 2014 43 47 24490030 PMC3896131
  60. Kritzer M.F. Kohama S.G. Ovarian hormones influence morphology, distribution and density of tyrosine hydroxylase immunoreactive axons in the dorsolateral prefrontal cortex of adult rhesus monkeys J. Comp. Neurol. 395 1998 1 17 9590542
  61. Kühn S. Gallinat J. Gray matter correlates of posttraumatic stress disorder: a quantitative meta-analysis Biol. Psychiatry 73 2013 70 74 22840760
  62. Lacerda-Pinheiro S.F. Pinheiro J.R.F. Lima M.A. Silva C.G. Santos M.D. Teixeira J.A.G. Oliveira P.N. Ribeiro K.D. Rolim-Neto M.L. Bianco B.A. Are there depression and anxiety genetic markers and mutations? A systematic review J. Affect Disord. 168C 2014 387 398 25106036
  63. Liston C. Miller M.M. Goldwater D.S. Radley J.J. Rocher A.B. Hof P.R. Morrison J.H. McEwen B.S. Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting J. Neurosci. 26 2006 7870 7874 16870732 PMC6674229
  64. Liston C. McEwen B.S. Casey B.J. Psychosocial stress reversibly disrupts prefrontal processing and attentional control Proc. Natl. Acad. Sci. U.S.A. 106 2009 912 917 19139412 PMC2621252
  65. Mao Z.-M. Arnsten A.F.T. Li B.-M. Local infusion of alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys Biol. Psychiatry 46 1999 1259 1265 10560031
  66. Matsumoto M. Hikosaka O. Two types of dopamine neuron distinctly convey positive and negative motivational signals Nature 459 2009 837 841 19448610 PMC2739096
  67. McNally R.J. Kaspi S.P. Riemann B.C. Zeitlin S.B. Selective processing of threat cues in posttraumatic stress disorder J. Abnorm. Psychol. 99 1990 398 402 2266215
  68. Melia K.R. Rasmussen K. Terwilliger R.Z. Haycock J.W. Nestler E.J. Duman R.S. Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus: effects of chronic stress and drug treatments J. Neurochem. 58 1992 494 502 1345939
  69. Miner L.H. Jedema H.P. Moore F.W. Blakely R.D. Grace A.A. Sesack S.R. Chronic stress increases the plasmalemmal distribution of the norepinephrine transporter and the coexpression of tyrosine hydroxylase in norepinephrine axons in the prefrontal cortex J. Neurosci. 26 2006 1571 1578 16452680 PMC6675488
  70. Mizoguchi K. Yuzuihara M. Ishige A. Sasaki H. Chui D.-H. Tabira T. Chronic stress induces impairment of spatial working memory due to prefrontal dopaminergic dysfunction J. Neurosci. 20 2000 1568 1575 10662846 PMC6772382
  71. Mollica R.F. Lyoo I.K. Chernoff M.C. Bui H.X. Lavelle J. Yoon S.J. Kim J.E. Renshaw P.F. Brain structural abnormalities and mental health sequelae in South Vietnamese ex-political detainees who survived traumatic head injury and torture Arch. Gen. Psychiatry 66 2009 1221 1232 19884610
  72. Murphy B.L. Arnsten A.F.T. Goldman-Rakic P.S. Roth R.H. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys Proc. Natl. Acad. Sci. U.S.A. 93 1996 1325 1329 8577763 PMC40079
  73. Nader K. LeDoux J.E. Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations Behav. Neurosci. 113 1999 891 901 10571473
  74. Nakama H. Garcia A. O'Brien K. Ellis N. Case report of a 24-year-old man with resolution of treatment-resistant major depressive disorder and comorbid PTSD using rTMS J. ECT 30 2014 e9 10 24553322
  75. Neafsey E.J. Prefrontal control of the autonomic nervous system: anatomical and physiological observations Prog. Brain Res. 85 1990 147 165 2094892
  76. Nestler E.J. Alreja M. Aghajanian G.K. Molecular control of locus coeruleus neurotransmission Biol. Psychiatry 46 1999 1131 1139 10560020
  77. Neylan T.C. Lenoci M. Samuelson K.W. Metzler T.J. Henn-Haase C. Hierholzer R.W. Lindley S.E. Otte C. Schoenfeld F.B. Yesavage J.A. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment Am. J. Psychiatry 163 2006 2186 2188 17151174
  78. Norrholm S.D. Jovanovic T. Smith A.K. Binder E. Klengel T. Conneely K. Mercer K.B. Davis J.S. Kerley K. Winkler J. Differential genetic and epigenetic regulation of catechol-O-methyltransferase is associated with impaired fear inhibition in Posttraumatic Stress Disorder Front. Behav. Neurosci. 7 2013 30 23596403 PMC3622057
  79. Oluwabusi O.O. Sedky K. Bennett D.S. Prazosin treatment of nightmares and sleep disturbances associated with posttraumatic stress disorder: two adolescent cases (Case Reports) J. Child. Adolesc. Psychopharmacol. 22 2012 399 402 23083029
  80. Ongür D. Price J.L. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans Cereb. Cortex 10 2000 206 219 10731217
  81. Peskind E.R. Bonner L.T. Hoff D.J. Raskind M.A. Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder J. Geriatr. Psychiatry Neurol. 16 2003 165 171 12967060
  82. Phillipson O.T. Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: a horseradish peroxidase study in the rat J. Comp. Neurol. 187 1979 117 143 489776
  83. Price J.L. Amaral D.G. An autoradiographic study of the projections of the central nucleus of the monkey amygdala J. Neurosci. 1 1981 1242 1259 6171630 PMC6564217
  84. de Quervain D.J. Kolassa I.T. Ackermann S. Aerni A. Boesiger P. Demougin P. Elbert T. Ertl V. Gschwind L. Hadziselimovic N. PKCα is genetically linked to memory capacity in healthy subjects and to risk for posttraumatic stress disorder in genocide survivors Proc. Natl. Acad. Sci. U.S.A. 109 2012 8746 8751 22586106 PMC3365172
  85. Rajkowski J. Kubiak P. Inanova S. Aston-Jones G. State-related activity, reactivity of locus coeruleus neurons in behaving monkeys Adv. Pharmacol. 42 1998 740 744 9328005
  86. Raskind M.A. Peskind E.R. Kanter E.D. Petrie E.C. Radant A. Thompson C. Dobie D.J. Hoff D. Rein R.J. Straits-Troster K. Reduction in nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study Am. J. Psychiatry 160 2003 371 373 12562588
  87. Raskind M.A. Peskind E.R. Hoff D.J. Hart K.L. Holmes H.A. Warren D. Shofer J. O'Connell J. Taylor F.B. Gross C. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder Biol. Psychiatry 61 2007 928 934 17069768
  88. Raskind M.A. Peterson K. Williams T. Hoff D.J. Hart K. Holmes H. Homas D. Hill J. Daniels C. Calohan J. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan Am. J. Psychiatry 170 2013 1003 1010 23846759
  89. Robbins T.W. Dissociating executive functions of the prefrontal cortex Phil. Trans. R. Soc. Lond. 351 1996 1463 1471 8941958
  90. Rodrigues S.M. LeDoux J.E. Sapolsky R.M. The influence of stress hormones on fear circuitry Annu. Rev. Neurosci. 32 2009 289 313 19400714
  91. Roozendaal B. McGaugh J.L. Memory modulation Behav. Neurosci. 125 2011 797 824 22122145 PMC3236701
  92. Sara S.J. Herve-Minvielle A. Inhibitory influence of frontal cortex on locus coeruleus Proc. Natl. Acad. Sci. U.S.A. 92 1995 6032 6036 7597075 PMC41636
  93. Seib L.M. Wellman C.L. Daily injections alter spine density in rat medial prefrontal cortex Neurosci. Lett. 337 2003 29 32 12524164
  94. Shansky R.M. Hamo C. Hof P.R. McEwen B.S. Morrison J.H. Stress-induced dendritic remodeling in the prefrontal cortex is circuit specific Cereb. Cortex 106 2009 17957 17962 PMC2742599 19193712
  95. Simons J.S. Henson R.N. Gilbert S.J. Fletcher P.C. Separable forms of reality monitoring supported by the anterior prefrontal cortex J. Cogn. Neurosci. 20 2008 447 457 18004946 PMC2292823
  96. Simpson T.L. Saxon A.J. Meredith C.W. Malte C.A. McBride B. Ferguson L.C. Gross C.A. Hart K.L. Raskind M. A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence Alcohol Clin. Exp. Res. 33 2009 255 263 18945226
  97. Sinha R. Li C.S. Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications Drug Alcohol Rev. 26 2007 25 31 17364833
  98. Southwick S.M. Krystal J.H. Morgan C.A. Johnson D. Nagy L.M. Nicolaou A. Heninger G.R. Charney D.S. Abnormal noradrenergic function in posttraumatic stress disorder Arch. Gen. Psychiatry 50 1993 266 274 8466387
  99. Stoddard F.J.J. Outcomes of traumatic exposure Child Adolesc. Psychiatr. Clin. N. Am. 23 2014 243 256 24656578
  100. Strawn J.R. Keeshin B.R. Successful treatment of posttraumatic stress disorder with prazosin in a young child Ann. Pharmacother. 45 2011 1590 1591 22116993
  101. Strawn J.R. Delbello M.P. Geracioti T.D. Prazosin treatment of an adolescent with posttraumatic stress disorder (Case Reports Letter) J. Child Adolesc. Psychopharmacol. 19 2009 599 600 19877989
  102. Su Y.A. Wu J. Zhang L. Zhang Q. Su D.M. He P. Wang B.D. Li H.S. Webster M.J. Group T.S.B.S. Dysregulated mitochondrial genes and networks with drug targets in postmortem brain of patients with posttraumatic stress disorder (PTSD) revealed by human mitochondria-focused cDNA microarrays Int. J. Biol. Sci. 4 2008 223 235 18690294 PMC2500154
  103. Subica A.M. Claypoole K.H. Wylie A.M. PTSD'S mediation of the relationships between trauma, depression, substance abuse, mental health, and physical health in individuals with severe mental illness: evaluating a comprehensive model Schizophr. Res. 136 2012 104 109 22104139
  104. Svensson T.H. Bunney B.S. Aghajanian G.K. Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine Brain Res. 92 1975 291 306 1174954
  105. Taylor F.B. Lowe K. Thompson C. McFall M.M. Peskind E.R. Kanter E.D. Allison N. Williams J.A. Martin P. Raskind M.A. Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder Biol. Psychiatry 59 2006 577 581 16460691
  106. Taylor F.B. Martin P. Thompson C. Williams J. Mellman T.A. Gross C. Peskind E.R. Raskind M.A. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study Biol. Psychiatry 63 2008 629 632 17868655 PMC2350188
  107. Thompson-Schill S.L. Jonides J. Marshuetz C. Smith E.E. D'Esposito M. Kan I.P. Knight R.T. Swick D. Effects of frontal lobe damage on interference effects in working memory Cogn. Affect Behav. Neurosci. 2 2002 109 120 12455679
  108. Tian F. Yennu A. Smith-Osborne A. Gonzalez-Lima F. North C.S. Liu H. Prefrontal responses to digit span memory phases in patients with post-traumatic stress disorder (PTSD): a functional near infrared spectroscopy study Neuroimage Clin. 4 2014 808 819 24936431 PMC4055895
  109. Tzavara E.T. Bymaster F.P. Overshiner C.D. Davis R.J. Perry K.W. Wolff M. McKinzie D.L. Witkin J.M. Nomikos G.G. Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine Mol. Psychiatry 11 2006 187 195 16231039
  110. Valentino R.J. Curtis A.L. Page M.E. Pavcovich L.A. Florin-Lechner S.M. Activation of the locus coeruleus brain noradrenergic system during stress: circuitry, consequences, and regulation Adv. Pharmacol. 42 1998 781 784 9328014
  111. Valentino R.J. Van Bockstaele E. Endogenous opioids: The downside of opposing stress Neurobiol. Stress 1 2015 23 32 25506603 PMC4260408
  112. Van Bockstaele E.J. Colago E.E. Valentino R.J. Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response J. Neuroendocrinol. 10 1998 743 757 9792326
  113. Vermetten E. Schmahl C. Southwick S.M. Bremner J.D. A Positron Tomographic Emission study of olfactory induced emotional recall in veterans with and without combat-related Posttraumatic Stress Disorder Psychopharmacol. Bull. 40 2007 8 30 17285093 PMC3236699
  114. Wang M.J. Yang Y. Wang C.J. Gamo N.J. Jin L.E. Mazer J.A. Morrison J.H. Wang X.-J. Arnsten A.F. NMDA receptors subserve working memory persistent neuronal firing in dorsolateral prefrontal cortex Neuron 77 2013 736 749 23439125 PMC3584418
  115. Weissman M.M. Livingston Bruce M. Leaf P.J. Florio L.P. Holzer C.I. Affective disorders Robins L.E. Regier D.A. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study 1991 The Free Press New York 53 80
  116. Zahrt J. Taylor J.R. Mathew R.G. Arnsten A.F.T. Supranormal stimulation of dopamine D1 receptors in the rodent prefrontal cortex impairs spatial working memory performance J. Neurosci. 17 1997 8528 8535 9334425 PMC6573725

Cited by

Sorted by citations

Authors
Arnsten, A. F. T., Raskind, M. A., Taylor, F. B., & Connor, D. F.
Affiliations
  • Yale University (US)
  • VA Puget Sound Health Care System (US)
  • University of Connecticut (US)
Corresponding author
Arnsten, Amy F.T.
Venue
Neurobiology of Stress
Publisher
Elsevier BV
Published
2015-01
Volume
1
Pages
89-99
ISSN
2352-2895 (ISSN-L)
OpenAlex
W1987605932
Cited by
381
References
38
Citations by year
2026: 36 · 2025: 39 · 2024: 36 · 2023: 33 · 2022: 35 · 2021: 34 · 2020: 39 · 2019: 39 · 2018: 29 · 2017: 29 · 2016: 23 · 2015: 9
FWCI
24.06
Type
journal article
Language
en
Open access
Locations
  • Neurobiology of Stress (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute on Aging (DP1AG047744)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
post-traumatic stress disorder, prefrontal cortex, chronic stress, noradrenergic system, alpha1-adrenoceptors, catecholamines, amygdala, dendritic atrophy, prazosin, guanfacine, clonidine, stress response, children and adolescents, veterans, impulse control

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review